Gifre, L.; Fusaro, M.; Lloret, M.J.; Massó, E.; Peris, P.; Nogués, X.; Gelpi, R.; Prior-Español, Á.; Ara, J.; Cozzolino, M.; et al. PTH Analog Therapy in CKD G4–G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease. J. Clin. Med. 2026, 15, 133. https://doi.org/10.3390/jcm15010133

AMA Style

Gifre L, Fusaro M, Lloret MJ, Massó E, Peris P, Nogués X, Gelpi R, Prior-Español Á, Ara J, Cozzolino M, et al. PTH Analog Therapy in CKD G4–G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease. Journal of Clinical Medicine. 2026; 15(1):133. https://doi.org/10.3390/jcm15010133

Chicago/Turabian Style

Gifre, Laia, Maria Fusaro, Maria J. Lloret, Elisabet Massó, Pilar Peris, Xavier Nogués, Rosana Gelpi, Águeda Prior-Español, Jordi Ara, Mario Cozzolino, and et al. 2026. "PTH Analog Therapy in CKD G4–G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease" Journal of Clinical Medicine 15, no. 1: 133. https://doi.org/10.3390/jcm15010133

APA Style

Gifre, L., Fusaro, M., Lloret, M. J., Massó, E., Peris, P., Nogués, X., Gelpi, R., Prior-Español, Á., Ara, J., Cozzolino, M., Ureña-Torres, P. A., & Bover, J. (2026). PTH Analog Therapy in CKD G4–G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease. Journal of Clinical Medicine, 15(1), 133. https://doi.org/10.3390/jcm15010133

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI